Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS)

BACKGROUND: Metastatic soft tissue sarcoma (STS) are a heterogeneous group of malignancies which are not curable with chemotherapy alone. Therefore, understanding the molecular mechanisms of sarcomagenesis and therapy resistance remains a critical clinical need. ASPP2 is a tumor suppressor, that fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsintari, Vasileia, Walter, Bianca, Fend, Falko, Overkamp, Mathis, Rothermundt, Christian, Lopez, Charles D., Schittenhelm, Marcus M., Kampa-Schittenhelm, Kerstin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250729/
https://www.ncbi.nlm.nih.gov/pubmed/35780096
http://dx.doi.org/10.1186/s12885-022-09726-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250729/
https://www.ncbi.nlm.nih.gov/pubmed/35780096
http://dx.doi.org/10.1186/s12885-022-09726-7

Ejemplares similares